Patents by Inventor Manuel Arzadon JAVIER, JR.

Manuel Arzadon JAVIER, JR. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and devices for endovascular ablation of a splanchnic nerve
    Patent number: 11806073
    Abstract: Systems, devices, and methods for transvascular ablation of target tissue. The devices and methods may, in some examples, be used for splanchnic nerve ablation to increase splanchnic venous blood capacitance to treat at least one of heart failure and hypertension. For example, the devices disclosed herein may be advanced endovascularly to a target vessel in the region of a thoracic splanchnic nerve (TSN), such as a greater splanchnic nerve (GSN) or a TSN nerve root. Also disclosed are methods of treating heart failure, such as HFpEF, by endovascularly ablating a thoracic splanchnic nerve to increase venous capacitance and reduce pulmonary blood pressure.
    Type: Grant
    Filed: October 22, 2021
    Date of Patent: November 7, 2023
    Assignee: Axon Therapies, Inc.
    Inventors: Anisha Bapna, Zoar Jacob Engelman, Howard Levin, Pajhand Iranitalab, Casey Andrew Miller, Thomas Ryan McGrath, Manuel Arzadon Javier, Jr.
  • Methods and devices for endovascular ablation of a splanchnic nerve
    Patent number: 11413090
    Abstract: Systems, devices, and methods for transvascular ablation of target tissue. The devices and methods may, in some examples, be used for splanchnic nerve ablation to increase splanchnic venous blood capacitance to treat at least one of heart failure and hypertension. For example, the devices disclosed herein may be advanced endovascularly to a target vessel in the region of a thoracic splanchnic nerve (TSN), such as a greater splanchnic nerve (GSN) or a TSN nerve root. Also disclosed are methods of treating heart failure, such as HFpEF, by endovascularly ablating a thoracic splanchnic nerve to increase venous capacitance and reduce pulmonary blood pressure.
    Type: Grant
    Filed: January 19, 2021
    Date of Patent: August 16, 2022
    Assignee: Axon Therapies, Inc.
    Inventors: Pajhand Iranitalab, Casey Andrew Miller, Thomas Ryan McGrath, Manuel Arzadon Javier, Jr., Anisha Bapna, Zoar Jacob Engelman, Howard Levin, Nicholas C. VanDillen, Anne Marie Ahonen
  • METHODS AND DEVICES FOR ENDOVASCULAR ABLATION OF A SPLANCHNIC NERVE
    Publication number: 20220039863
    Abstract: Systems, devices, and methods for transvascular ablation of target tissue. The devices and methods may, in some examples, be used for splanchnic nerve ablation to increase splanchnic venous blood capacitance to treat at least one of heart failure and hypertension. For example, the devices disclosed herein may be advanced endovascularly to a target vessel in the region of a thoracic splanchnic nerve (TSN), such as a greater splanchnic nerve (GSN) or a TSN nerve root. Also disclosed are methods of treating heart failure, such as HFpEF, by endovascularly ablating a thoracic splanchnic nerve to increase venous capacitance and reduce pulmonary blood pressure.
    Type: Application
    Filed: October 22, 2021
    Publication date: February 10, 2022
    Inventors: Anisha BAPNA, Zoar Jacob ENGELMAN, Howard LEVIN, Pajhand IRANITALAB, Casey Andrew MILLER, Thomas Ryan MCGRATH, Manuel Arzadon JAVIER, JR.
  • METHODS AND DEVICES FOR ENDOVASCULAR ABLATION OF A SPLANCHNIC NERVE
    Publication number: 20210220043
    Abstract: Systems, devices, and methods for transvascular ablation of target tissue. The devices and methods may, in some examples, be used for splanchnic nerve ablation to increase splanchnic venous blood capacitance to treat at least one of heart failure and hypertension. For example, the devices disclosed herein may be advanced endovascularly to a target vessel in the region of a thoracic splanchnic nerve (TSN), such as a greater splanchnic nerve (GSN) or a TSN nerve root. Also disclosed are methods of treating heart failure, such as HFpEF, by endovascularly ablating a thoracic splanchnic nerve to increase venous capacitance and reduce pulmonary blood pressure.
    Type: Application
    Filed: January 19, 2021
    Publication date: July 22, 2021
    Inventors: Pajhand IRANITALAB, Casey Andrew MILLER, Thomas Ryan McGRATH, Manuel Arzadon JAVIER, JR., Anisha BAPNA, Zoar Jacob ENGELMAN, Howard LEVIN, Nicholas C. VanDILLEN, Anne Marie AHONEN